surmount 1 tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial SURMOUNT-1: Tirzepatide Drastically Reduces Weight – surmount-1 tirzepatide weight loss percent

Retrieved from National Library of Medicine: MedlinePlus

Patients curious about it should hear from a physician about what is actually known and what is not

In conclusion, the study found that semaglutide, in combination with lifestyle intervention, was associated with a sustained and clinically relevant reduction in body weight in individuals with overweight or obesity

Only about 18% of people with opioid use disorder and an even smaller percentage with alcohol use disorder receive medication-assisted treatment

But with all that information out there, it can be hard to find out who it's for and how to get it

Polycystic ovarian syndrome (PCOS) is a condition that likely has a large blood sugar component